Guideline of the German respiratory society for diagnosis and treatment of patients suffering from acute or chronic cough;Leitlinie der Deutschen gesellschaft für pneumologie zur diagnostik und therapie von patienten mit akutem und chronischem husten

Pneumologie

Volumn 58, Issue 8, 2004, Pages 570-602

  Kardos, P ^a,m   Cegla, U ^b   Gillissen, A ^c   Kirsten, D ^d   Mitfessel, H ^e   Morr, H ^f   Schultze Werninghaus, G ^g   Sitter, H ^h   Vogelmeier, C ^h   Voshaar, T ⁱ   Worth, H ^j   Eckardt, V ^k   Klimek, L ^l  

^a Gemeinschaftspraxis Radiologie   (Germany)

^b Herz Jesu Krankenhaus Dernbach   (Germany)

^c Robert Koch Klinik   (Germany)

^d KRANKENHAUS GROSSHANSDORF   (Germany)

^e Krankenhaus Wermelskirchen   (Germany)

^f Pneumologische Klin Waldhof E   (Germany)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁱ Krankenhaus Bethanien   (Germany)

^j KLINIKUM FÜRTH   (Germany)

^k DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^l Zentrum Rhinologie und Allergologie   (Germany)

^m Zentrum F Rhinologie Allergologie ^*  (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; ANTIBIOTIC AGENT; BROMHEXINE; CEFOTIAM; CINEOLE; CLOBUTINOL; CODEINE; COLISTIN; DEXTROMETHORPHAN; DORNASE ALFA; GUAIFENESIN; NOSCAPINE; PENTOXYVERINE; POTASSIUM BICARBONATE; THEOPHYLLINE; THYMOL; TOBRAMYCIN;

ASPIRATION; BRONCHOSPASM; CONSTIPATION; COUGHING; DEPRESSION; DRUG DEPENDENCE; DRUG HYPERSENSITIVITY; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTHYROIDISM; LUNG FUNCTION; MEDICAL SOCIETY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN TOXICITY;

EID: 4344658718     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818356     Document Type: Review

References (227)

1. Gesellschaft für Pädiatrische Pneumologie. Leitlinie der Gesellschaft für Pädiatrische Pneumologie. Husten. Hofmann D http://www.awmf-online.de/, 1998
2. Dt. Ges. f. Hals-Nasen-Ohren-Heilkunde KuH-C. Leitlinie Reizhusten/Räusperzwang Kinder (Klinischer Algorithmus). HNO-Mitteilungen 1997; 45 (3): 7S-7S
3. Irwin RS, Boulet LP, Cloutier MM et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998; 114(2): 133S-181
4. Society for Medical Decision Making. Committee on standardization of clinical algorithms Proposals for clinical algorithm standards. Med Decis Making 1992; 12: 49-154
5. Schappert SM. National ambulatory medical care survey: 1991. Summary 1993; 230: 1-20
6. Anon Y. Office Visits to Internists: The National Ambulatory Medical Care Survey 1975. Vital and Health Statistics Series 13. 1978; 36: 29
7. Roche N, Huchon G. Du symptome au diagnostic: toux. Pneumologie 1997; 6-090 (A-15): 6-6
8. Kirsten D. Die Top-ten der Pneumologie. Hamburg: Kongress der Deutschen Gesellschaft für Pneumologie 2000
9. Kanzow G, Kirsten D, Magnussen H. Stufendiagnostik in der Pneumologie am Beispiel der Leitsymptome: Husten, Hämoptysen, Dyspnoe. Internist 1996; 37: 132-139
10. Widdicombe JG. Neurophysiology of the cough reflex. Eur Respir J 1995; 8 (7): 1193-1202
11. Braman SS, Corrao WM. Cough: differential diagnosis and treatment. Clin Chest Med 1987; 8 (2): 177-188
12. Kardos P. Chronisch persistierender Husten (CHP). Pneumologie 1995; 49 (1): 2-13
13. Irwin R. Cough. In: Irwin R, Curley F, Grossmann R. Symptoms of the Respiratory Tract. USA: Futura Publishing Company Inc., Armonk, N.Y, 1997; (1): 1-54
14. Kohler D, Vastag E. Bronchiale Clearance. Pneumologie 1991; 45 (5): 314-332
15. Salem H, Aviado D. Antitussive Drugs. Am J Med Sci 1964; 247: 585-600
16. Pomerantz M, Braman S. Cough Reflexes in Asthma. Am Rev Respir Dis 1992; A12: 89
17. Sheppard D, Rizk NW, Boushey HA et al. Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am Rev Respir Dis 1983; 127 (6): 691-694
18. Lalloo UG, Barnes PJ, Chung KF. Pathophysiology and clinical presentations of cough. J Allergy Clin lmmunol 1996; 98 (5 Pt 2): S91-S96
19. Chang AB, Gibson PG. Relationship between cough, cough receptor sensitivity and asthma in children. PuIm Pharmacol Ther 2002; 15 (3): 287-291
20. Smyrnios NA, Irwin RS, Curley FJ. Chronic Cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 1995; 108 (4): 991-997
21. Corren J. The Impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 1998; 101 (2 PT 2): S352-S356
22. Poe RH, Israel RH, Utell MJ et al. Chronic Cough: Bronchoscopy or pulmonary function testing? Am Rev Respir Dis 1982; 126(1): 160-162
23. Poe RH, Harder RV, Israel RH et al. Chronic Persistent Cough. Experience in Diagnosis and outcome using an anatomic diagnostic protocol. Chest 1989; 95 (4): 723-728
24. Holinger LD, Sanders AD. Chronic Cough in infants and children: an update. Laryngoscope 1991; 101 (6 PT 1): 596-605
25. Mello CJ, Irwin RS, Curley FJ. Predictive Values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med 1996; 156 (9): 997-1003
26. Kardos P, Gebhardt T. Chronisch persistierender Husten (CPH) in der Praxis: Diagnostik und Therapie bei 329 Patienten in 2 Jahren. Pneumologie 1996; 50(6): 437-441
27. Palombini BC, Villanova CA, Araújo E et al. A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest 1999; 116(2): 279-284
28. Irwin RS, Corrao WM, Pratter MR. Chronic Persistent Cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981; 123 (4 PT 1): 413-417
29. McGarvey LP, Heaney LG, Lawson JT et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998; 53 (9): 738-743
30. Irwin RS, Madison JM. Review Articles Primary Care: The Diagnosis and Treatment of Cough. The New England Journal of Medicine 2000; 343 (23): 1715-1721
31. Irwin RS, Madison JM. The Persistently Troublesome Cough. American Journal of Respiratory and Critical Care Medicine 2002; 165 (11): 1469-1474
32. Macfarlane JT, Colville A, Guion A et al. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993; 341 (8844): 511-514
33. Arroll B, Kenealy T. Antibiotics for acute bronchitis. BMJ 2001; 322 (7292): 939-940
34. Heikkinen T, Järvinen A. The common cold. Lancet 2003; 361 (9351): 51-59
35. Interdisziplinäre Arbeitsgruppe "Allergische Rhinitis" der Sektion HNO Allergische Rhinokonjunktivitis. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie. Allergo J 2003; 12 (4): 182-194
36. Wettengel R, Berdel D, Hofmann D et al. Empfehlungen für Asthmatherapie bei Kindern und Erwachsenen. Pneumologie 1998; 52 (11): 591-601
37. Barber CM, Curran AD, Fishwick D et al. Impaired cough reflex in patients with recurrent pneumonia. Thorax 2003; 58(7): 645-646
38. Worth H, Adam D, Handrick W et al. Prevention und Therapie von bronchialen Infektionen. Empfehlungen der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie. Pneumologie 1998; 52(4): 232-237
39. Stein PD, Willis PW, DeMets DL. History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease. Am J Cardiol 1981; 47 (2): 218-223
40. Meissner E, Niedermeyer J, Worth H et al. Diagnose der akuten Lungenembolie. Empfehlungen der Deutschen Gesellschaft für Pneumologie. Pneumologie 2000; 54 (12): 587-591
41. Brunnee T, Graf K, Kastens B et al. Bronchial hyperreactivity in patients with moderate pulmonary circulation overload. Chest 1993; 103 (5): 1477-1481
42. Pison C, Malo JL, Rouleau JL et al. Bronchial hyperresponsiveness to inhaled methacholine in subjects with chronic left heart failure at a time of exacerbation and after increasing diuretic therapy. Chest 1989; 96 (2): 230-235
43. Lee D, Beldner S, Pollaro F et al. Cough-induced heart block. Pacing Clin Electrophysiol 1999; 22 (8): 1270-1271
44. Baron SB, Huang SK. Cough syncope presenting as Mobitz type II atrioventricular block - an electrophysiologic correlation. Pacing Clin Electrophysiol 1987; 10 (1 Pt 1): 65-69
45. Saito D, Matsuno S, Matsushita K et al. Cough syncope due to atrioventricular conduction block. Jpn Heart J 1982; 23 (6): 1015-1020
46. Hart G, Oldershaw PJ, Cull RE et al. Syncope caused by cough-induced complete atrioventricular block. Pacing Clin Electrophysiol 1982; 5 (4): 564-566
47. Mitton M. Paroxysmal atrioventricular block in a healthy patient receiving spinal anesthesia: a case report. AANA J 1993; 61 (6): 605-609
48. Worth H, Buhl R, Cegla U et al. Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Lungenerkrankung (COPD). Pneumologie 2002; 56 (11): 704-738
49. Lee JJ, Lin RL, Chen CH et al. Clinical manifestations of bronchogenic carcinoma. J Formos Med Assoc 1992; 91 (2): 146-151
50. Hyde L, Hyde CI. Clinical manifestations of lung cancer. Chest 1974; 65 (3): 299-306
51. Saito Y, Nagamoto N, Ota S et al. Results of surgical treatment for roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 1992; 104 (2): 401-407
52. Thomas M, Gatzemeier U, Goerg R et al. Empfehlungen zur Diagnostik des Bronchialkarzinoms. Pneumologie 2000; 54 (8): 361-371
53. Thomas M, Baumann M, Deppermann M et al. Empfehlungen zur Therapie des Bronchialkarzinoms. Pneumologie 2002; 56 (2): 113-131
54. Fontana GA, Lavorini F, Pistolesi M. Water aerosols and cough. Pulm Pharmacol Ther 2002; 15 (3): 205-211
55. Ebihara S, Saito H, Kanda A et al. Impaired Efficacy of Cough in Patients With Parkinson Disease. Chest 2003; 124 (3): 1009-1015
56. Lalloo UG, Lim S, DuBois R et al. Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease. Eur Respir J 1998; 11 (3): 702-705
57. Spira A, Grossman R, Baiter M. Large airway disease associated with inflammatory bowel disease. Chest 1998; 113 (6): 1723-1726
58. Lengyel C, Boros I, Varkonyi T et al. (Amiodarone-induced pulmonary fibrosis). Orv Hetil 1996; 137 (32): 1759-1762
59. Imokawa S, Colby TV, Leslie KO et al. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15 (2): 373-381
60. Strimlan CV, Rosenow EC, Divertie MB et al. Pulmonary manifestations of Sjoegren's syndrome. Chest 1976; 70 (03); 354-361
61. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjoegren's syndrome. Clin Chest Med 1998; 19 (4): 687-99, viii
62. Ukena D, Harnest U, Sakalauskas R et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur Respir J 1997; 10 (12): 2754-2460
63. Larson TS, Hall S, Hepper NG et al. Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med 1984; 101 (5): 594-597
64. Olopade CO, Sekosan M, Schraufnagel DE. Giant Cell Arteritis Manifesting as chronic cough and fever of unknown origin. Mayo Clin Proc 1997; 72 (11): 1048-1050
65. Breton JL, Ranfaing E, Depierre A et al. (Bronchial involvement disclosing Wegener's granulomatosis). Rev Mal Respir 1986; 3 (3): 153-155
66. Daum TE, Specks U, Colby TV et al. Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 1995; 151 (2 Pt 1): 522-526
67. Camus P, Piard F, Ashcroft T et al. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993; 72 (3): 151-183
68. Bargon J, Rust M, Kardos P et al. Salazosulfapyridine-induzierte eosinophile Pneumonie mit pulmonaler und kutaner epitheloidzelliger Granulomatose bei Sjögren syndrome. Pneumologie 1990; 44 (4): 744-750
69. Shub C, Alexander BB. Persistent cough - the presenting feature in unsuspected sarcoidosis: a case report. Mil Med 1971; 136 (9): 757-758
70. Baughman RP, Iannuzzi MC, Lower EE et al. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19 (3): 198-204
71. Usalan C, Emri S. Exertional dyspnoea and nonproductive cough in a 22-year-old man. Postgrad Med J 2000; 76 (892): 115-117
72. Kirsten D. Deutsche Gesellschaft für Pneumologie: Empfehlungen für Diagnosis und Therapie der Sarkoidose. Pneumologie 1998; 52 (1): 26-30
73. Fink JB. Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care 2000; 45 (6): 623-635
74. Rapti A, Drossos C, Tzavelas D et al. Mounier-Kuhn syndrome (tracheobronchomegaly). Monaldi Arch Chest Dis 1995; 50 (3): 195-198
75. Schwanz M, Rossoff L. Tracheobronchomegaly. Chest 1994; 106 (5): 1589-1590
76. Kirchner J, Jacobi V, Kardos P et al. CT findings in extensive tracheobronchial amyloidosis. Eur Radiol 1998; 8 (3): 352-354
77. Molina JF, Espinoza LR. Relapsing polychondritis. Baillieres Best Pract Res Clin Rheumatol 2000; 14 (1): 97-109
78. Leske V, Lazor R, Coetmeur D et al. Tracheobronchopathia osteochondroplastica: a study of 41 patients. Medicine (Baltimore) 2001; 80 (6): 378-390
79. Sutor GC, Glaab T, Eschenbruch C et al. Tracheobronchopathia osteochondroplastica: eine ungewöhnliche Ursache einer Retentionspneumonie. Pneumologie 2001; 55 (12): 563-567
80. Sen RP, Walsh TE. Fiberoptic bronchoscopy for refractory cough. Chest 1991; 99 (1): 33-35
81. Walther EK, Herberhold C. Die Behandlung der laryngotrachealen Papillomatose mit kombinierter Laserchirurgie und localer Administration von α-Interferon (Roferon). Laryngorhinootologie 1993; 72 (10): 485-491
82. Guillou L, Sahli R, Chaubert P et al. Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol 1991; 15 (9): 891-898
83. Sweriduk ST, DeLuca SA. Juvenile laryngotracheal papillomatosis. Am Fam Physician 1986; 33 (4): 155-156
84. Schonhofer B, Voshaar T, Kohler D. Long-term lung sequelae following accidental chlorine gas exposure. Respiration 1996; 63 (3): 155-159
85. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 1985; 88 (3): 376-384
86. Brooks SM, Hammad Y, Richards I et al. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 1998; 113 (1): 42-49
87. Christopher KL, Wood RP, Eckert RC et al. Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983; 308 (26): 1566-1570
88. Newman KB, Mason UG, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995; 152 (4 Pt 1): 1382-1386
89. Thomas PS, Geddes DM, Barnes PJ. Pseudo-steroid resistant asthma. Thorax 1999; 54 (4): 352-356
90. Kenn K, Schmitz M. Vocal cord dysfunction, eine wichtige Differenzialdaignose des schweren Asthma bronchiale. Pneumologie 1997; 51 (1): 14-18
91. Ip MS, So SY, Lam WK et al. Endobronchial tuberculosis revisited. Chest 1986; 89 (5): 727-730
92. Lee JH, Park SS, Lee DH et al. Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases (published erratum appears in Chest 1993; 103 (5): 1640). Chest 1992; 102 (4): 990-994
93. Pierson DJ, Lakshminarayan S, Petty TL. Endobronchial tuberculosis. Chest 1973; 64 (4): 537-539
94. Schaberg T, Forssbohm M, Hauer B et al. Richtlinien zur medikamentösen Behandlung der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 2001 ; 55 (11): 494-511
95. Wright SW, Edwards KM, Decker MD et al. Pertussis infection in adults with persistent cough. JAMA 1995; 273 (13): 1044-1046
96. Birkebaek NH, Kristiansen M, Seefeldt T et al. Bordetella pertussis and chronic cough in adults. Clin Infect Dis 1999; 29 (5): 1239-1242
97. Jackson LA, Cherry JD, Wang SP et al. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis 2000; 31 (1): 3-6
98. Vincent JM, Cherry JD, Nauschuetz WF et al. Prolonged afebrile non-productive cough illnesses in American soldiers in Korea: a serological search for causation. Clin Infect Dis 2000; 30 (3): 534-539
99. Martin L, Gustaferro C. Chronic Cough Associated With Subacute Bacterial endocarditis. Mayo Clin Proc 1995; 70 (7): 662-664
100. Irwin RS, Rosen MJ, Braman SS. Cough. A comprehensive review. Arch Intern Med 1977; 137 (9): 1186-1191
101. Irwin RS, Curley FJ, French CL. Chronic Cough. The Spectrum And Frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141 (3): 640-647
102. Holinger LD. Chronic Cough In Infants And Children. Laryngoscope 1986; 96 (3): 316-322
103. Federspil P. Antibiotische Therapie von Infektionen im Bereich von Kopf und Hals. Deutsche Gesellschaft für Hals-, Nasen-, Ohrenheil-kunde, Kopf- und Halschirurgie. Laryngorhinootologie 2000; 79 (6): 366-377
104. Dt. Ges. f. Hals-Nasen-Ohren-Heilkunde KuH-C. Leitlinie Reizhusten/Räusperzwang Erwachsene (Klinischer Algorithmus). HNO-Mitteilungen 1997; 47 (3): 6S-6S
105. Berg P, Wehrli R, Medici TC. Asthmahusten. Das monosymptomatische Bronchialasthma in Form von chronischem Husten. Dtsch Med Wochenschr 1986; 111 (45): 1730-1731
106. Connell EJ, Rojas AR, Sachs MI. Cough-type asthma: a review. Ann Allergy 1991; 66 (4): 278-282, 285
107. Corrao WM, Braman SS, Irwin RS. Chronic Cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 1979; 300 (12): 633-637
108. Frans A, Eeckhaut J Van Den. Cough as the sole manifestation of airway hyperreactivity. J Laryngol Otol 1989; 103 (7): 680-682
109. Johnson D, Osborn LM. Cough Variant Asthma: A review of the clinical literature. J Asthma 1991; 28 (2): 85-90
110. Nowak D, Heinrich J, Jorres R et al. Prevalence of respiratory symptoms, bronchial hyperresponsiveness and atopy among adults: west and east Germany. Eur Respir J 1996; 9 (12): 2541-2552
111. Sears MR, Jones DT, Holdaway MD et al. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax 1986; 41 (4): 283-289
112. Dicpinigaitis P. Zafirlukast in cough-variant asthma. J Asthma 2002; 39: 291-297
113. Fujimura M, Ogawa H, Nishizawa Y et al. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax 2003; 58 (1): 14-18
114. Hollenz M, Stolte M, Labenz J. Prevalänz des gastro- ösophagealen Refluxes in der Allgemeinpraxis. Dtsch Med Wochenschr 2002; 127 (19): 1007-1012
115. Peterson W. Improving the Management of GERD. Evidence-based therapeutic strategies. American Gastroenterological Association Consensus Development Panel. AGA Edition, 2002
116. Marchesani F, Cecarini L, Pela R et al. Causes of chronic persistent cough in adult patients: the results of a systematic management protocol. Monaldi Arch Chest Dis 1998; 53 (5): 510-514
117. Schnatz PF, Castell JA, Castell DO. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol 1996; 91 (9): 1715-1718
118. Paterson WG, Murat BW. Combined ambulatory esophageal manometry and dual-probe pH-metry in evaluation of patients with chronic unexplained cough. Dig Dis Sci 1994; 39 (5): 1117-1125
119. Ing AJ, Ngu MC, Breslin AB. Chronic Persistent Cough And Gastro-oesophageal Reflux. Thorax 1991; 46 (7): 479-483
120. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101 (4 Pt 2 Suppl 53): 1-78
121. Poe RH, Kallay MC. Chronic Cough and Gastroesophageal Reflux Disease: Experience With Specific Therapy for Diagnosis and Treatment. Chest 2003; 123 (3): 679-684
122. Schmidt D, Jorres RA, Magnussen H. Citric acid-induced cough thresholds in normal subjects, patients with bronchial asthma, and smokers. Eur J Med Res 1997; 2 (9): 384-388
123. Avidan B, Sonnenberg A, Schnell TG et al. Temporal associations between coughing or wheezing and acid reflux in asthmatics. Gut 2001; 49 (6): 767-772
124. Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH-testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 1999; 115 (3): 654-659
125. Irwin RS, French CL, Curley FJ et al. Chronic Cough Due To Gastroesophageal Reflux. Clinical, diagnostic, and pathogenetic aspects (see comments). Chest 1993; 104 (5): 1511-1517
126. Ours TM, Kavuru MS, Schilz RJ et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94 (11): 3131-3138
127. Jaspersen D, Diehl KL, Weber R. Diagnostischer Omeprazoltest bei Verdacht auf refluxassoziierten chronisch persistierenden Husten. Pneumologie 1999; 53 (3): S64-S64
128. Vaezi MF, Richter JE. Twenty-four-hour Ambulatory Esophageal PH Monitoring In the diagnosis of acid reflux-related chronic cough. South Med J 1997; 90 (3): 305-311
129. Lazenby JP, Harding SM. Chronic cough, asthma, and gastroesophageal reflux. Curr Gastroenterol Rep 2000; 2 (3): 217-223
130. Fraser AG, Morton RP, Gillibrand J. Presumed laryngo-pharyngeal reflux: investigate or treat? J Laryngol Otol 2000; 114 (6): 441-447
131. Leite LP, Johnston BT, Just RJ et al. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996; 91 (8): 1527-1531
132. Katzka DA, Paoletti V, Leite L et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996; 91 (10): 2110-2113
133. Johnston BT, Gideon RM, Castell DO. Excluding gastroesophageal reflux disease as the cause of chronic cough. J Clin Gastroenterol 1996; 22 (3): 168-169
134. Irwin RS. Silencing chronic cough. Hosp Pract (Off Ed) 1999; 34 (1): 53-30
135. Irwin RS, Zawacki JK, Wilson MM et al. Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 2002; 121 (4): 1132-1140
136. Novitsky YW, Zawacki JK, Irwin RS et al. Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surg Endosc 2002; 16 (4): 567-571
137. McGarvey LP, Forsythe P, Heaney LG et al. Bronchoalveolar lavage findings in patients with chronic nonproductive cough. Eur Respir J 1999; 13 (1): 59-65
138. Lee SY, Cho JY, Shim JJ et al. Airway inflammation as an assessment of chronic nonproductive cough. Chest 2001; 120 (4): 1114-1120
139. Nelson S, Summer WR, Mason CM. The role of the inflammatory response in chronic bronchitis: therapeutic implications. Semin Respir Infect 2000; 15 (1): 24-31
140. Kanner RE, Connett JE, Williams DE et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 1999; 106 (4): 410-416
141. Krzyzanowski M, Robbins DR, Lebowitz MD. Smoking cessation and changes in respiratory symptoms in two populations followed for 13 years. Int J Epidemiol 1993; 22 (4): 666-673
142. Tashkin DP, Clark VA, Coulson AH et al. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. Am Rev Respir Dis 1984; 130 (5): 707-715
143. Kastelik JA, Jackson W, Davies TW et al. Measurement of Gastric Emptying in Gastroesophageal Reflux-Related Chronic Cough. Chest 2002; 122 (6): 2038-2041
144. Fujimoto T, Hillejan L, Stamatis G. Current strategy for surgical management of bronchiectasis. The Annals of Thoracic Surgery 2001; 72 (5): 1711-1715
145. Kutlay H, Cangir AK, Enon S et al. Surgical treatment in bronchiectasis: analysis of 166 patients. European Journal of Cardio-Thoracic Surgery 2002; 21 (4): 634-637
146. Agasthian T, Deschamps C, Trastek VF et al. Surgical Management of Bronchiectasis. The Annals of Thoracic Surgery 1996; 62 (4): 976-978
147. Prieto D, Bernardo J, Matos MJ et al. Surgery for bronchiectasis. European Journal of Cardio-Thoracic Surgery 2001; 20 (1): 19-24
148. Morice AH, Lowry R, Brown MJ et al. Angiotensin-converting enzyme and the cough reflex. Lancet 1987; 2 (8568): 1116-1118
149. Fuller RW. Cough provocation tests: their clinical value. Pulm Pharmacol Ther 2002; 15 (3): 273-276
150. Birring SS, Brightling C, Symon F et al. Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 2003; 58: 1066-1070
151. Lee PC, Cotterill J, Eccles R. Voluntary control of cough. Pulm Pharmacol Ther 2002; 15 (3): 317-320
152. French C, Irwin RS, Curley FG et al. Impact of chronic cough on quality of life. Arch Intern Med 1998; 158 (15): 1657-1661
153. Choudry NO, Fuller RW, Pride NB. Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis 1989; 140 (1): 137-141
154. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117 (3): 234-242
155. Lacourciere Y, Brunner H, Irwin R et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens 1994; 12 (12): 1387-1393
156. Imaizumi H, Kaneko M, Mori K et al. Reversible acquired tracheobronchomalacia of a combined crescent type and saber-sheath type. J Emerg Med 1995; 13 (1): 43-49
157. Gibson PG, Dolovich J, Denburg J et al. Chronic Cough: Eosinophilic Bronchitis Without Asthma. Lancet 1989; 1 (8651): 1346-1348
158. Kardos P. Eosinophile Bronchitis ohne Asthma: eine weitere seltene Ursache für chronisch persistierenden Husten? Pneumologie 2001; 55 (5): 249-252
159. Kujat A, Gillissen A, Zuber MA. Genetische Diagnose und Beratung bei Bronchiektasie. Erstdiagnose der zystischen Fibrose bei Erwachsenen. Dtsch Med Wochenschr 2002; 127 (10): 501-502
160. Macfarlane J, Holmes W, Gard P et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56: 109-104
161. Verheij TJ, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract 1994; 44 (386): 400-404
162. Morice AH, Widdicombe J, Dicpinigaitis P et al. Understanding cough. Eur Respir J 2002; 19 (1): 6-7
163. Mortensen J, Falk M, Groth S et al. The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis. Chest 1991; 100 (5): 1350-1357
164. Gosselink R. Therapie, Training, Tests. van den Berg F. Angewandte Physiologie 2001; (3): 275-276
165. Hardy KA, Anderson BD. Noninvasive clearance of airway secretions. Respir Care Clin N Am 1996; 2 (2): 323-345
166. Jones A, Rowe B. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. The Cochrane Library 2002; 2: Letzte update 01.2003
167. Rubin BK. The pharmacologic approach to airway clearance: mucoactive agents. Respir Care 2002; 47 (7): 818-822
168. Mazzocco MC, Owens GR, Kirilloff LH et al. Chest percussion and postural drainage in patients with bronchiectasis. Chest 1985; 88 (3): 360-363
169. Gallon A. Evaluation of chest percussion in the treatment of patients with copious sputum production. Respir Med 1991; 85 (1): 45-51
170. Sutton PP, Lopez V, Pavia D et al. Assessment of percussion, vibratory-shaking and breathing exercises in chest physiotherapy. Eur J Respir Dis 1985; 66 (2): 147-152
171. Sutton PP, Parker RA, Webber BA et al. Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur J Respir Dis 1983; 64 (1): 62-68
172. Lannefors L, Wollmer P. Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: a comparison between postural drainage, PEP and physical exercise. Eur Respir J 1992; 5 (6): 748-753
173. Miller S, Hall DO, Clayton CB et al. Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax 1995; 50 (2): 165-169
174. Lauber B, Lauber J. Krankengymnastische Atemtherapie. Nolte D Manuale Pneumologicum 1992; (IV-12): 7
175. Cegla UH, Retzow A. Physiotherapy mit VRP1 bei chronisch obstruktiven Atemwegserkrankungen. Ergebnisse einer multizentrischen Vergleichsstudie. Pneumologie 1993; 47 (11): 636-639
176. Thompson CS, Harrison S, Ashley J et al. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax 2002; 57 (5): 446-448
177. Cegla UH, Bautz M, Frode G et al. Physiotherapie bei Patienten mt COPD und tracheobronchialer Instabilität. Vergleich von zwei oszillierenden PEP Systemen (RC-Cornet, VRP1 Desitin). Ergebnisse einer randomisierten, prospektiven Studie mit 90 Patienten. Pneumologie 1997; 51 (2): 129-136
178. Hausen T. Therapie von obstruktiven Atemwegserkrankungen. MMW-Fortschr Med 1991; 46; 700-703
179. Lurie A, Mestiri M, Huchon G et al. Methods for clinical assessment of expectorants: a critical review. Int J Clin Pharmacol Res 1992; 12 (1): 47-52
180. Gillissen A, Tasci S, Ewig S et al. Sinn und Unsinn von Antitussiva. Internist (Berl) 2001; 42 (1): 134-142
181. Rubin BK. The pharmacologic approach to airway clearance: muco-active agents. Respir Care 2002; 47 (7): 818-822
182. Schroeder K, Fahey T. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. BMJ 2002; 324 (7333): 329
183. Ziment I. Herbal antitussives. Pulm Pharmacol Ther 2002; 15 (3): 327-333
184. Köhler D. Inhalationstherapie bei chronischer Schleimretention. Pneumologie 1990; 44 (10): 1166-1170
185. Haidl P, Schonhofer B, Siemon K et al. Inhaled isotonic alkaline versus saline solution and radioaerosol clearance in chronic cough. Eur Respir J 2000; 16 (6): 1102-1108
186. Laube BL, Auci RM, Shields DE et al. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am J Respir Crit Care Med 1996; 153 (2): 752-760
187. Robinson PJ. Dornase alfa in early cystic fibrosis lung disease. Pediatr Pulmonol 2002; 34 (3): 237-241
188. Ghafouri MA, Patil KD, Kass I. Sputum changes associated with the use of ipratropium bromide. Chest 1984; 86 (3): 387-393
189. Holmes PW, Barter CE, Pierce RJ. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med 1992; 86 (5): 425-429
190. Lowry R, Wood A, Johnson T et al. Antitussive properties of inhaled bronchodilators on induced cough. Chest 1988; 93 (6): 1186-1189
191. Higenbottam TW. Anticholinergics and cough. Postgrad Med J 1987; 63 Suppl 1: 75-78
192. Shore SC, Weinberg EG. Ipratropium bromide inhalation for allergic rhinitis and chronic cough. S Afr Med J 1981; 59 (8): 252-252
193. Tay HL, Armoogum N, Tan LK. Nasal mucociliary clearance and salmeterol. Clin Otolaryngol 1997; 22 (1): 68-70
194. Mortensen J, Lange P, Nyboe J et al. Lung mucociliary clearance. Eur J Nucl Med 1994; 21 (9): 953-961
195. Hueston W. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract 1991; 33 (5): 476-480
196. 2-agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review. J Fam Pract 2001; 50 (11): 945-951
197. Curley FJ, Irwin RS, Pratter MR et al. Cough and the common cold. Am Rev Respir Dis 1988; 138 (2): 305-311
198. Corrao WM. Chronic Persistent Cough: Diagnosis and treatment update. Pediatr Ann 1996; 25 (3): 162-168
199. Pratter MR, Bartter T, Akers S et al. An Algorithmic approach to chronic cough. Ann Intern Med 1993; 119 (10): 977-983
200. Angrill J, Agusti C, De Celis R et al. Bronchial Inflammation and Colonization in Patients with Clinically Stable Bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2001; 164 (9): 1628-1632
201. Schaefer O, Irwin R. Chronic cough due to clinically silent suppurative disease of the airways: a new clinical entity (abstract). Am J Respir Crit Care Med 1999; 159 (Part 2): A830
202. Barker AF, Couch LESL, Fiel SB et al. Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2000; 162 (2): 481-485
203. Ramsey BW, Pepe MS, Quart JM et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. The New England Journal of Medicine 1999; 340 (1): 23-30
204. Kalliomaki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357 (9262): 1076-1079
205. Tamm M, Eich C, Frei R et al. Inhalierbares Colistin bei zystischer Fibrose. Schweiz Med Wochenschr 2000; 130 (39): 1366-1372
206. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90 (1): 32-42
207. Higenbottam T. Cough induced by changes of ionic composition of airway surface liquid. Bull Eur Physiopathol Respir 1984; 20 (6): 553-562
208. Chan PW, Debruyne JA. Inhaled nedocromil sodium for persistent cough in children. Med J Malaysia 2001; 56 (4): 408-413
209. Young IH. Nedocromil sodium (Tilade) metered aerosol in the treatment of chronic cough. Med J Aust 1996; 164 (12): 755-755
210. Moroni M, Porta C, Gualtieri G et al. Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients. Br J Cancer 1996; 74 (2): 309-311
211. Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J Asthma 2002; 39 (4): 291-297
212. Hansson L, Midgren B, Karlsson JA. Effects of inhaled lignocaine and adrenaline on capsaicin-induced cough in humans. Thorax 1994; 49 (11): 1166-1168
213. Karlsson JA. Airway anaesthesia and the cough reflex. Bull Eur Physiopathol Respir 1987; 23 Suppl 10: 29s-36s
214. Fuller RW, Jackson DM. Physiology and treatment of cough. Thorax 1990; 45 (6): 425-430
215. Fuller RW, Karlsson JA, Choudry NB et al. Effect of inhaled and systemic opiates on responses to inhaled capsaicin in humans. J Appl Physiol 1988; 65 (3): 1125-1130
216. Eccles R. The powerful placebo in cough studies? Pulm Pharmacol Ther 2002; 15 (3): 303-308
217. Taylor JA, Novack AH, Almquist JR et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122 (5 Pt 1): 799-802
218. Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 1992; 17 (3): 175-180
219. Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration 1998; 65 (1): 86-88
220. Dicpinigaitis PV, Dobkin JB. Antitussive effect of the GABA-agonist baclofen. Chest 1997; 111 (4): 996-999
221. Irwin RS, Curley FJ. The treatment of cough. A comprehensive review. Chest 1991; 99 (6): 1477
222. George L, Rehman SU, Khan FA. Diaphragmatic rupture: A complication of violent cough. Chest 2000; 117 (4): 1200-1201
223. Prasad S, Baur LA. Fracture of the first rib as a consequence of pertussis infection. J Paediatr Child Health 2001; 37 (1): 91-93
224. De Maeseneer M, De Mey J, Debaere C et al. Rib fractures induced by coughing: an unusual cause of acute chest pain. Am J Emerg Med 2000; 18 (2): 194-197
225. Mattle HP, Nirkko AC, Baumgartner RW et al. Transient cerebral circulatory arrest coincides with fainting in cough syncope. Neurology 1995; 45 (3 Pt 1): 498-501
226. Tanaka T, Inoue H, Aizawa H et al. Case of cough syncope with seizure. Respiration 1994; 61 (1): 48-50
227. Kopp I, Müller W, Lorenz W. Die zentrale Rolle von Outcome in Leitlinien und Disease-Management Programmen. 8. Rundbrief. AWMF online, 2003: 1-10